Recombinant Human UBE2I Protein，His

UBE2I, also known as Ubiquitin-conjugating enzyme E2 I, is a critical member of the ubiquitin-proteasome system (UPS), which plays a fundamental role in regulating various cellular processes, including protein degradation, cell cycle progression, and responses to stress. UBE2I primarily functions by conjugating ubiquitin to target proteins, thereby marking them for degradation or modulating their activity and localization. Recent studies have highlighted its involvement in the regulation of key pathways associated with cancer, neurodegenerative disorders, and immune responses, making it a potential therapeutic target. Additionally, UBE2I is implicated in the modification of proteins involved in the DNA damage response, further emphasizing its importance in maintaining cellular homeostasis. The study of UBE2I as a recombinant protein has gained traction as researchers seek to elucidate its specific functions, interactions with various E3 ligases, and its contribution to disease pathology. Understanding the structure-function relationships of UBE2I and its regulatory mechanisms could provide insights for the development of novel therapeutic strategies, particularly in cancers where proteostasis is disrupted. Thus, the exploration of UBE2I in a recombinant form is essential for advancing our knowledge of ubiquitin signaling and its implications in health and disease.